| Prevention of HIV-1 infection with early antiretroviral therapy MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England journal of medicine 365 (6), 493-505, 2011 | 8737 | 2011 |
| Zika virus infection in pregnant women in Rio de Janeiro P Brasil, JP Pereira Jr, ME Moreira, RM Ribeiro Nogueira, L Damasceno, ... New England Journal of Medicine 375 (24), 2321-2334, 2016 | 2347 | 2016 |
| Antiretroviral therapy for the prevention of HIV-1 transmission MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England Journal of Medicine 375 (9), 830-839, 2016 | 1815 | 2016 |
| Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ... The Lancet infectious diseases 14 (4), 281-290, 2014 | 631 | 2014 |
| No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis JL Marcus, DV Glidden, KH Mayer, AY Liu, SP Buchbinder, KR Amico, ... PloS one 8 (12), e81997, 2013 | 299 | 2013 |
| Three postpartum antiretroviral regimens to prevent intrapartum HIV infection K Nielsen-Saines, DH Watts, VG Veloso, YJ Bryson, EC Joao, JH Pilotto, ... New england Journal of medicine 366 (25), 2368-2379, 2012 | 271 | 2012 |
| A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 MR O’Donnell, B Grinsztejn, MJ Cummings, JE Justman, MR Lamb, ... The Journal of clinical investigation 131 (13), 2021 | 194 | 2021 |
| Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind, placebo-controlled trial K Mulligan, DV Glidden, PL Anderson, A Liu, V McMahan, P Gonzales, ... Clinical infectious diseases 61 (4), 572-580, 2015 | 189 | 2015 |
| Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial B Grinsztejn, N De Castro, V Arnold, VG Veloso, M Morgado, JH Pilotto, ... The Lancet infectious diseases 14 (6), 459-467, 2014 | 133 | 2014 |
| Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial SH Eshleman, SE Hudelson, AD Redd, L Wang, R Debes, YQ Chen, ... The Journal of infectious diseases 204 (12), 1918-1926, 2011 | 131 | 2011 |
| Maternal Zika virus disease severity, virus load, prior dengue antibodies, and their relationship to birth outcomes UA Halai, K Nielsen-Saines, ML Moreira, PC de Sequeira, JPP Junior, ... Clinical Infectious Diseases 65 (6), 877-883, 2017 | 115 | 2017 |
| Knowledge, perceived stigma, and care-seeking experiences for sexually transmitted infections: a qualitative study from the perspective of public clinic attendees in Rio de … M Malta, FI Bastos, SA Strathdee, SD Cunnigham, JH Pilotto, D Kerrigan BMC public health 7, 1-8, 2007 | 103 | 2007 |
| Early mortality and cause of deaths in patients using HAART in Brazil and the United States B Grinsztejn, VG Veloso, RK Friedman, RI Moreira, PM Luz, DP Campos, ... Aids 23 (16), 2107-2114, 2009 | 95 | 2009 |
| Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission K Adachi, JD Klausner, CC Bristow, J Xu, B Ank, MG Morgado, DH Watts, ... Sexually transmitted diseases 42 (10), 554-565, 2015 | 91 | 2015 |
| Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study N Yeganeh, HD Watts, M Camarca, G Soares, E Joao, JH Pilotto, G Gray, ... The Pediatric infectious disease journal 34 (3), e52-e57, 2015 | 85 | 2015 |
| Treatment as prevention: characterization of partner infections in the HIV prevention trials network 052 trial SH Eshleman, SE Hudelson, AD Redd, R Swanstrom, SS Ou, XC Zhang, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (1), 112-116, 2017 | 81 | 2017 |
| Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women B Grinsztejn, VG Veloso, JE Levi, L Velasque, PM Luz, RK Friedman, ... International Journal of Infectious Diseases 13 (1), 72-80, 2009 | 77 | 2009 |
| Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052) JM Fogel, L Wang, TL Parsons, SS Ou, E Piwowar-Manning, Y Chen, ... The Journal of infectious diseases 208 (10), 1624-1628, 2013 | 76 | 2013 |
| Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected pregnant women and adverse infant outcomes K Adachi, JD Klausner, J Xu, B Ank, CC Bristow, MG Morgado, DH Watts, ... The Pediatric infectious disease journal 35 (8), 894-900, 2016 | 68 | 2016 |
| Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study) EP Nunes, M Santini de Oliveira, M Merçon, R Zajdenverg, JC Faulhaber, ... HIV Clinical Trials 10 (6), 368-374, 2009 | 63 | 2009 |
